TrakCel Revenue and Competitors

Claim your profile

Waterfront 2000, UK



Total Funding



Estimated Revenue & Valuation

  • TrakCel's estimated annual revenue is currently $12.6M per year.(i)
  • TrakCel received $Undisclosed in venture funding in October 2016.
  • TrakCel's estimated revenue per employee is $155,000

Employee Data

  • TrakCel has 81 Employees.(i)
  • TrakCel grew their employee count by 0% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation

There are few other fields of medicine that require the level of mass customisation of production and careful orchestration of production pathways that Cell, Gene and Immunotherapies demand. A critical factor facing the industry is choosing technologies and partners that can deliver scale. From sample collection through logistics, manufacturing and final treatment, TrakCel's proven technology integrates and orchestrates every aspect of a clinical program and commercial product with comprehensive chain of custody, chain of identity and traceability throughout.



Total Funding


Number of Employees


Revenue (est)


Employee Growth %





TrakCel News

2021-03-05 - TrakCel Receives Strategic Investment

TrakCel, a Cardiff, Wales-based supplier of cellular orchestration solutions supporting the cell and gene therapy industry, closed its latest funding round of undisclosed amount. The round was led by AmerisourceBergen and Labcorp (NYSE: LH). These funds will enable further transformation of Tr ...

2019-08-14 - Supply chain to supply 'cycle': TrakCel CEO talks cell and ...

The increasing number of cell and gene therapies in clinical development is evolving the supply chain into a 'supply cycle,' says TrakCel CEO, ...

2019-06-24 - Be The Match and TrakCel partner on integrated services for ...

Be The Match BioTherapies and TrakCel form a strategic partnership to integrate their offering for companies developing cell and gene ...

2019-06-18 - and TrakCel Partner to Standardize Cell and Gene Therapy ...

“Be The Match BioTherapies and TrakCel share the goal of ensuring that the next generation of cell and gene therapies can be developed ...

2016-10-19 - TrakCel Receives an Equity Investment from Telegraph Hill Partners

TrakCel, a Cardiff, Wales, UK-based cellular orchestration platform developer, received a multi-million dollar investment from San Francisco-based Telegraph Hill Partners. The company intends to use the funds for growth activities. Concurrent with the financing, Matt Mackowski, Tom Raffin M.D., ...

TrakCel Funding

DateAmountRoundLead InvestorsReference
2016-10-21$UndisclosedUndisclosedTelegraph Hill Partners.Article